ASX - By Stock
|
MSB |
Thoughts on FDA, potential Ryoncil approval and Gift Horses
|
|
Naughty Morty
|
1 |
1.2K |
44 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
1
|
1.2K
|
44
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Annual Report to Shareholders
|
|
Naughty Morty
|
29 |
5.1K |
6 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
29
|
5.1K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Annual Report to Shareholders
|
|
Naughty Morty
|
29 |
5.1K |
7 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
29
|
5.1K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
Naughty Morty
|
299 |
138K |
11 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
138K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
COVID ARDS interim analysis
|
|
Naughty Morty
|
37 |
20K |
10 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
37
|
20K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
Naughty Morty
|
1.0K |
490K |
51 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
1.0K
|
490K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast(?) Australian Covid-19 Trial Victor Chang Cardiac Research Institute
|
|
Naughty Morty
|
86 |
44K |
3 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
86
|
44K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Naughty Morty
|
17K |
6.7M |
9 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Naughty Morty
|
17K |
6.7M |
13 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
|
|
Naughty Morty
|
276 |
140K |
28 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
276
|
140K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review
|
|
Naughty Morty
|
131 |
54K |
7 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
131
|
54K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts BLA for RYONCIL and Agrees to Priority Review
|
|
Naughty Morty
|
131 |
54K |
15 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
131
|
54K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Naughty Morty
|
17K |
6.7M |
4 |
26/01/20 |
26/01/20 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Naughty Morty
|
17K |
6.7M |
3 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Naughty Morty
|
23K |
13M |
12 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Naughty Morty
|
888 |
644K |
0 |
09/01/20 |
09/01/20 |
Charts
|
888
|
644K
|
0
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Naughty Morty
|
888 |
644K |
1 |
09/01/20 |
09/01/20 |
Charts
|
888
|
644K
|
1
|
|
Charts
|
MSB |
Re:
MSB Charts
|
|
Naughty Morty
|
888 |
644K |
6 |
08/01/20 |
08/01/20 |
Charts
|
888
|
644K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
Naughty Morty
|
73 |
48K |
11 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
73
|
48K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
Naughty Morty
|
73 |
48K |
10 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
73
|
48K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
Naughty Morty
|
73 |
48K |
11 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
73
|
48K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
Naughty Morty
|
73 |
48K |
34 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
73
|
48K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Naughty Morty
|
4.4K |
2.4M |
4 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Let me clarify
|
|
Naughty Morty
|
73 |
33K |
3 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
73
|
33K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
All Aboard
|
|
Naughty Morty
|
51 |
23K |
13 |
09/11/18 |
09/11/18 |
ASX - By Stock
|
51
|
23K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
All Aboard
|
|
Naughty Morty
|
51 |
23K |
6 |
07/11/18 |
07/11/18 |
ASX - By Stock
|
51
|
23K
|
6
|
|
ASX - By Stock
|
SPL |
Dendrimer Manufacturing cGMP
|
|
Naughty Morty
|
1 |
765 |
1 |
06/11/18 |
06/11/18 |
ASX - By Stock
|
1
|
765
|
1
|
|
ASX - By Stock
|
MSB |
Re:
All Aboard
|
|
Naughty Morty
|
51 |
23K |
11 |
06/11/18 |
06/11/18 |
ASX - By Stock
|
51
|
23K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Expands Partnership With JCR For Skin Disease
|
|
Naughty Morty
|
54 |
20K |
2 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
54
|
20K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Completion of Tasly Transaction, and Appendix 3B
|
|
Naughty Morty
|
15 |
8.5K |
7 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
15
|
8.5K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
1 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
1 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
1 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Odd Shares / Sell Question
|
|
Naughty Morty
|
15 |
6.1K |
3 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
15
|
6.1K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
Naughty Morty
|
3.4K |
1.3M |
1 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
0 |
01/10/18 |
01/10/18 |
ASX - By Stock
|
34
|
16K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
3 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
34
|
16K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
2 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
34
|
16K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
1 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
2 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
34
|
16K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
BP buy recommend & price target $3.95
|
|
Naughty Morty
|
34 |
16K |
1 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
34
|
16K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Shorting hypotheses
|
|
Naughty Morty
|
2 |
1.3K |
4 |
24/09/18 |
24/09/18 |
ASX - By Stock
|
2
|
1.3K
|
4
|
|
ASX - By Stock
|
MSB |
Shorting hypotheses
|
|
Naughty Morty
|
2 |
1.3K |
6 |
21/09/18 |
21/09/18 |
ASX - By Stock
|
2
|
1.3K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial
|
|
Naughty Morty
|
79 |
31K |
3 |
20/09/18 |
20/09/18 |
ASX - By Stock
|
79
|
31K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial
|
|
Naughty Morty
|
79 |
31K |
1 |
20/09/18 |
20/09/18 |
ASX - By Stock
|
79
|
31K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial
|
|
Naughty Morty
|
79 |
31K |
0 |
20/09/18 |
20/09/18 |
ASX - By Stock
|
79
|
31K
|
0
|
|